Monoclonal Mouse anti‑Human BIRC5 / Survivin Antibody (Biotin, aa1‑142, WB) LS‑C298130
Monoclonal Mouse anti‑Human BIRC5 / Survivin Antibody (Biotin, aa1‑142, WB) LS‑C298130
Antibody:
BIRC5 / Survivin Mouse anti-Human Monoclonal (aa1-142) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
BIRC5 / Survivin Mouse anti-Human Monoclonal (aa1-142) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
Survivin antibody LS-C298130 is a biotin-conjugated mouse monoclonal antibody to human Survivin (BIRC5) (aa1-142). Validated for WB.
Target
Human BIRC5 / Survivin
Synonyms
BIRC5 | API4 | Apoptosis inhibitor survivin | Apoptosis inhibitor 4 | Survivin | Survivin variant 3 alpha | EPR-1 | IAP4
Reactivity
Human
(tested or 100% immunogen sequence identity)
Purification
Affinity purified
Immunogen
Recombinant Surv (Met1-Asp142) expressed in E. coli.
Specificity
Human BIRC5 / Survivin
Applications
- Western blot (1:100 - 1:400)
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Short term: store at 4°C for up to 4 weeks. Long term: aliquot and store at -20°C to -70°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, ICC, Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
Western blot, Immunoprecipitation, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Flow Cytometry, ELISA
Species:
Human
Applications:
ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/29/2024